Audentes Therapeutics (NASDAQ: BOLD) Takeover
Audentes Therapeutics (BOLD) Merger – Acquisition Details
Astellas (ALPMF) and Audentes Therapeutics (BOLD) $3bn merger information is displayed in the deal information table below. This factsheet including expected completion date and offer price is an invaluable data source for traders & investors looking to familiarize themselves with the Astellas (ALPMF) takeover of Audentes Therapeutics (BOLD) and trade the merger arbitrage spread.
